J0715 HCPCS Level II code: Injection, ceftizoxime sodium, per 500 mg

CMS terminated J0715: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.

Official description

J0715

Injection, ceftizoxime sodium, per 500 mg

Short description: Ceftizoxime sodium / 500 mg

HCPCS · United States

Medicare details

The indicators CMS publishes with J0715 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Jan 1, 1995
Terminated after
Dec 31, 2025

Where J0715 sits

  1. 1J codesDrugs administered other than orally
  2. 2Terminated J0715Injection, ceftizoxime sodium, per 500 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

Is HCPCS code J0715 still valid?

No. CMS terminated J0715; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.

Does Medicare cover J0715?

CMS lists J0715’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.